Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 30;8(3):455-465.
doi: 10.9745/GHSP-D-20-00135. Print 2020 Sep 30.

Factors Associated With Delayed Contraceptive Implant Removal in Ethiopia

Elizabeth Costenbader  1 , Alice F Cartwright  2 , Misti McDowell  3 , Berhane Assefa  4 , Meza Yirga Tejeji  3 , Eskindir Tenaw  3
Affiliations

Factors Associated With Delayed Contraceptive Implant Removal in Ethiopia

Elizabeth Costenbader et al. Glob Health Sci Pract. .

Abstract

Background: In 2009, the Government of Ethiopia initiated the implant scale-up initiative, which expanded contraceptive access by training health extension workers (HEWs) to insert single-rod etonogestrel contraceptive implants (Implanon) at rural health posts. Removals were provided by referrals to higher levels of the health system. However, little was known about whether women were getting their implants removed at the recommended 3-year postinsertion date or what barriers they faced to removal.

Methods: Between June and July 2016, 1,860 Ethiopian women, who had a 1-rod etonogestrel implant inserted by either an HEW or another health care provider between 3 and 6 years prior, were surveyed. We describe the characteristics of the sample and use multivariable logistic regression to predict factors associated with keeping implants inserted beyond 3 years.

Results: Women who had received their implants from HEWs were significantly more likely to report keeping them inserted for more than 3 years (adjusted odds ratio=2.50; 95% confidence interval=1.19, 5.24), compared with those who got their implant from another health care provider. Women who reported distance to the facility or transportation as a barrier were also significantly more likely to keep their implant for more than 3 years. Married and educated women were less likely to keep their implants for an extended duration. Among women who had their implant for 3 years or less, women who had had it inserted by an HEW were significantly more likely to report that the provider was unable or refused to provide removal as a barrier.

Discussion: Efforts to expand lower level and community-based access to contraceptive implants that do not ensure reliable access to removals at the same level as insertions may lead to women using implants beyond the recommended duration.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Number of Implanon Users Surveyed in Ethiopia, by Region Abbreviation: SNNPR, Southern Nations, Nationalities, and Peoples’ Region.
See this image and copyright information in PMC

References

    1. Olson DJ, Piller A. Ethiopia: an emerging family planning success story. Stud Fam Plann. 2013;44(4):445–459. 10.1111/j.1728-4465.2013.00369.x. - DOI - PubMed
    1. Addis Ababa University School of Public Health; Bill & Melinda Gates Institute for Population and Reproductive Health at the Johns Hopkins Bloomberg School of Public Health. Performance Monitoring and Accountability 2020 (PMA2020) Survey Round 6, PMA2018/Ethiopia-R6 Snapshot of Indicators. 2018. Accessed August 3, 2020. https://www.pma2020.org/pma2018-ethiopia-round-6-snapshot-indicators-table
    1. Asnake M, Henry EG, Tilahun Y, Oliveras E. Addressing unmet need for long-acting family planning in Ethiopia: uptake of single-rod progestogen contraceptive implants (Implanon) and characteristics of users. Int J Gynaecol Obstet. 2013;123(Suppl 1):e29–e32. 10.1016/j.ijgo.2013.07.003. - DOI - PubMed
    1. Tilahun Y, Lew C, Belayihun B, Lulu Hagos K, Asnake M. Improving contraceptive access, use, and method mix by task sharing Implanon insertion to frontline health workers: the experience of the Integrated Family Health Program in Ethiopia. Glob Health Sci Pract. 2017;5(4):592–602. 10.9745/GHSP-D-17-00215. - DOI - PMC - PubMed
    1. Merck Sharp & Dohme Corporation. IMPLANON® (etonogestrel implant) for Subdermal Use: Prescribing Information. Merck Sharp & Dohme Corporation; 2011. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021529s008lblr...

Publication types

LinkOut - more resources